This is as per Kagome’s Q2 presentation (Apr to June):
Kagome started consolidating PBI into their accounts from end of May this year. Their estimate of sales for the last two quarters (July-December) for PBI is 3.4 billion Yen (185 crores) . This is derived from Kagome presentation that says:
“Net Sales Plan by Segment FY2015 2nd Half: Net increase in sales by PBI (U.S.) (+¥3.4 billion). A weak yen will also have favorable impact.”
This is from Kagome’s 9 months (Jan to Sept) consolidated results:
The performance for PBI is from May end to September end (4 months) is sales of 5.18 billion Yen ( 282 crores). This is derived from Kagome’s statement that says:
“Sales to major food services customers were strong at Kagome Inc. Net sales at United Genetics Holdings LLC were at roughly the same level as the same period of the previous year, but there was net increase of sales at Preferred Brands International (“PBI”), which was made a consolidated subsidiary at the end of May 2015. As a result, net sales in the U.S. were up 37.4% from the same period of the previous year at ¥19.035 billion.”
Comparing this to last year (PBI) again from the presentation: In the period ended March 31, 2015, net sales reached ¥5.0 billion (272 crores), and operating income was ¥500 million (27.2 crores). – Revenue has increased over each of the past 7 periods, with an average growth rate of 17%/year.
Either I am interpreting something incorrect or it looks like PBI is having a dream run with May to September sales being greater than last year sales. For all the data and presentations you can look here:
http://www.kagome.co.jp/company/ir/data/fy/index.html
Disclosure: Invested at an average price of 600 it forms more than 10% of my portfolio allocation. No transactions in last 6 months.
| Subscribe To Our Free Newsletter |
